Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Syros Pharmaceuticals, Inc.
Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome
January 26, 2023
From
Syros Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SYRS
Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
September 16, 2022
From
Syros Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SYRS
Syros and Tyme Technologies Announce Stockholder Approval of Merger
September 15, 2022
From
Syros Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SYRS
TYME
Syros Receives FDA Orphan Drug Designation for SY-5609 for the Treatment of Pancreatic Cancer
September 13, 2022
From
Syros Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SYRS
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.